跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Neubicyte - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Neubicyte
Approved
STANDARD
Neubicyte
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a211c4da230051b8
Company
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
Type
Standard
Approval Details
Approval Id
a211c4da230051b8
Drug Approval Philippines Name
Neubicyte
Product Name
Neubicyte
Registration Number
BR-1337
Brand Name
Neubicyte
Generic Name
Filgrastim
Dosage Form
Solution for Injection
Dosage Strength
300mcg/mL
Manufacturer
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
28 January 2021
Expiry Date
28 January 2026
Pharmacologic Category
Hematopoietic Growth Factor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a211c4da230051b8
Type
Standard
Back to Philippines FDA Approvals